---
figid: PMC3817019__dddt-7-1315Fig1
figtitle: 'How the VEGF-A signaling pathway is linked to its main biological functions.Notes:
  VEGF-A can bind VEGFR-2 dimer'
organisms:
- NA
pmcid: PMC3817019
filename: dddt-7-1315Fig1.jpg
figlink: /pmc/articles/PMC3817019/figure/f1-dddt-7-1315/
number: F1
caption: 'Schematic representation of how the VEGF-A signaling pathway is linked to
  its main biological functions.Notes: VEGF-A can bind VEGFR-2 dimer. NRP-1 and -2
  are co-receptors that stabilize the VEGFR-2 dimer. Upon ligand binding to VEGFR-2
  dimer, several signaling pathways can be activated, affecting diverse biological
  processes in endothelial and cancer cells. Anti-VEGF-A mAbs, such as bevacizumab
  or the fusion protein aflibercept, can bind to VEGF-A and block its function.Abbreviations:
  mAb, monoclonal antibody; NRP, neuropilin; VEGF, vascular endothelial growth factor;
  VEGFR, VEGF receptor; PKC, protein kinase C; PLC, phospholipase C; FAK, focal adhesion
  protein; TSAd-Src, T cell-specific adaptor protein containing an Src homology.'
papertitle: Molecularly targeted drugs for metastatic colorectal cancer.
reftext: Ying-dong Cheng, et al. Drug Des Devel Ther. 2013;7:1315-1322.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9583965
figid_alias: PMC3817019__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3817019__F1
ndex: 0c0e9893-dea3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3817019__dddt-7-1315Fig1.html
  '@type': Dataset
  description: 'Schematic representation of how the VEGF-A signaling pathway is linked
    to its main biological functions.Notes: VEGF-A can bind VEGFR-2 dimer. NRP-1 and
    -2 are co-receptors that stabilize the VEGFR-2 dimer. Upon ligand binding to VEGFR-2
    dimer, several signaling pathways can be activated, affecting diverse biological
    processes in endothelial and cancer cells. Anti-VEGF-A mAbs, such as bevacizumab
    or the fusion protein aflibercept, can bind to VEGF-A and block its function.Abbreviations:
    mAb, monoclonal antibody; NRP, neuropilin; VEGF, vascular endothelial growth factor;
    VEGFR, VEGF receptor; PKC, protein kinase C; PLC, phospholipase C; FAK, focal
    adhesion protein; TSAd-Src, T cell-specific adaptor protein containing an Src
    homology.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - NRP1
  - NELL1
  - NRP2
  - NELL2
  - KDR
  - PTK2
  - PLCG1
  - AKT1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PSMC6
  - CDKL1
  - CDK20
  - NUP43
  - H3P30
  - GTF2H2
  - IFI44
  - WDR77
  - H3P33
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - Cancer
---
